The Aspirin-Guide app from researchers at Brigham and Women's Hospital, Harvard Medical School, helps clinicians decide which patients are candidates for the use of low-dose aspirin in the primary prevention of atherosclerotic cardiovascular disease by balancing the ASCVD benefits against the risk of harm due to gastrointestinal or other bleeding.